Nishinaka Anri, Tanaka Miruto, Aoshima Kota, Kuriyama Aika, Sasaki Takahiro, Otsu Wataru, Yasuda Hiroto, Nakamura Shinsuke, Shimazawa Masamitsu, Hara Hideaki
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, Gifu, Japan.
FASEB J. 2022 Jun;36(6):e22323. doi: 10.1096/fj.202101917R.
Neovascular glaucoma (NVG) is caused by the formation of new blood vessels in the angle, iris, and cornea in retinal ischemic disease, such as proliferative diabetic retinopathy (PDR) and retinal vein occlusion (RVO), which can reduce the visual acuity. However, the pathophysiological symptoms of NVG are still not well understood because there is no model for the formation of NVG in the angle, iris, and cornea. The aim of this study was to investigate the involvement of NVG during ischemic disease, in a murine model of retinal ischemia. We evaluated the changes of the intraocular pressure (IOP) and pathological symptoms in the anterior eye segment and retina in this model, and the changes in the RNA or protein expression of vascular endothelial growth factor (VEGF) and fibrosis-related factors were analyzed in the retina and cornea by quantitative real-time polymerase chain reaction or western blot, respectively. Furthermore, we examined the changes in IOP after intravitreal injection of an anti-VEGF antibody. First, NVG formed in the retinal ischemic murine model, and the IOP was elevated in mice with NVG formation. Interestingly, VEGF expression was decreased in the retina but increased in the cornea in the murine model of NVG. On the other hand, fibrosis-related factors were increased in the retina and also significantly increased in the cornea in NVG. Moreover, the administration of anti-VEGF antibody immediately after vessel occlusion suppressed the increase in IOP, but administration at 7 days after vessel occlusion accelerated the increase in IOP. These findings suggest that the formation of NVG may be correlated with the pathological symptoms of retinal ischemic disease, via changes in VEGF and fibrosis-related factor expression.
新生血管性青光眼(NVG)是由视网膜缺血性疾病(如增殖性糖尿病视网膜病变(PDR)和视网膜静脉阻塞(RVO))导致房角、虹膜和角膜新生血管形成引起的,可降低视力。然而,由于缺乏房角、虹膜和角膜新生血管形成的模型,NVG的病理生理症状仍未得到充分了解。本研究的目的是在视网膜缺血小鼠模型中研究NVG在缺血性疾病中的作用。我们评估了该模型眼前节和视网膜的眼压(IOP)变化及病理症状,并分别通过定量实时聚合酶链反应或蛋白质印迹分析了视网膜和角膜中血管内皮生长因子(VEGF)和纤维化相关因子的RNA或蛋白质表达变化。此外,我们检测了玻璃体内注射抗VEGF抗体后眼压的变化。首先,在视网膜缺血小鼠模型中形成了NVG,且形成NVG的小鼠眼压升高。有趣的是,在NVG小鼠模型中,视网膜中VEGF表达降低,而角膜中VEGF表达升高。另一方面,纤维化相关因子在视网膜中增加,在NVG的角膜中也显著增加。此外,血管阻塞后立即给予抗VEGF抗体可抑制眼压升高,但在血管阻塞后7天给予则加速眼压升高。这些发现表明,NVG的形成可能通过VEGF和纤维化相关因子表达的变化与视网膜缺血性疾病的病理症状相关。